Neuroimaging study measures brain activity under psychedelic medicines
Kernel has published results from its Cybin-sponsored neuroimaging study which show the ability of Kernel’s Flow1 system to capture and analyse brain changes induced by psychedelics.
To date, real-time quantification of brain activity during the psychedelic experience has been a major barrier to psychedelics research. Many studies rely on subjective self-reporting, and fMRI machines can pose challenges due to high running costs and the experience for the participant of being in an fMRI whilst under the influence of a psychedelic is not ideal.
However, Kernel’s Flow1 device enables this real-time data collection of brain activity during the experience thanks to the use of near-infrared spectroscopy, providing measurements of blood oxygenation changes in the brain associated with neural activity.
READ MORE
